Evaluating the prevalence and risk factors of sarcopenia in elderly patients with type 2 diabetes mellitus in a Chinese hospital setting.

IF 1.8 Q4 ENDOCRINOLOGY & METABOLISM Journal of Diabetes and Metabolic Disorders Pub Date : 2024-10-01 eCollection Date: 2024-12-01 DOI:10.1007/s40200-024-01504-5
Shiyue Zou, Tingying Xiao, Mengyao Liu, Li Zhong, Ximin Mou, Jing Lai
{"title":"Evaluating the prevalence and risk factors of sarcopenia in elderly patients with type 2 diabetes mellitus in a Chinese hospital setting.","authors":"Shiyue Zou, Tingying Xiao, Mengyao Liu, Li Zhong, Ximin Mou, Jing Lai","doi":"10.1007/s40200-024-01504-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to assess the prevalence and risk factors associated with sarcopenia among hospitalized elderly Chinese patients with Type 2 Diabetes Mellitus (T2DM) to inform more effective management and prevention strategies.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis of 263 elderly T2DM patients in a hospital in Chengdu, China. Sarcopenia was diagnosed using the 2019 criteria from the Asian Working Group for Sarcopenia (AWGS). Multifactorial logistic regression analysis was employed to explore the determinants of sarcopenia among these patients.</p><p><strong>Results: </strong>The study revealed a sarcopenia prevalence of 42.2% among hospitalized elderly patients with T2DM, with men at 49.44% and women at 38.51%. Patients with sarcopenia were older (72.21 ± 6.841 years vs. 68.55 ± 5.585 years) and had lower Short Physical Performance Battery scores(SPPB), grip strength, and appendicular skeletal muscle mass index(ASMI) compared to non-sarcopenic patients (<i>p</i> < 0.001). Sarcopenia significantly impacted body composition, reducing muscle mass and body water and increasing visceral fat (<i>p</i> < 0.001). Logistic regression identified body mass index (BMI)(OR = 0.476, 95%CI: 0.352-0.642), skeletal muscle (OR = 0.274, 95%CI: 0.183-0.409), being female (OR = 0.001, 95%CI: 0.000-0.007) and handgrip strength (OR = 0.911, 95%CI: 0.842-0.986) as protective factors against sarcopenia, while higher waist circumference (OR = 1.186, 95%CI: 1.057-1.331) was significant risk factors.</p><p><strong>Conclusions: </strong>Key strategies to manage sarcopenia in elderly T2DM patients include maintaining an optimal BMI, strengthening grip, regular body composition assessments, and controlling waist circumference. These measures improve muscle strength, reduce risks from visceral fat, and enhance patient outcomes and quality of life.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"23 2","pages":"2365-2374"},"PeriodicalIF":1.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11599695/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes and Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-024-01504-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aimed to assess the prevalence and risk factors associated with sarcopenia among hospitalized elderly Chinese patients with Type 2 Diabetes Mellitus (T2DM) to inform more effective management and prevention strategies.

Methods: We conducted a cross-sectional analysis of 263 elderly T2DM patients in a hospital in Chengdu, China. Sarcopenia was diagnosed using the 2019 criteria from the Asian Working Group for Sarcopenia (AWGS). Multifactorial logistic regression analysis was employed to explore the determinants of sarcopenia among these patients.

Results: The study revealed a sarcopenia prevalence of 42.2% among hospitalized elderly patients with T2DM, with men at 49.44% and women at 38.51%. Patients with sarcopenia were older (72.21 ± 6.841 years vs. 68.55 ± 5.585 years) and had lower Short Physical Performance Battery scores(SPPB), grip strength, and appendicular skeletal muscle mass index(ASMI) compared to non-sarcopenic patients (p < 0.001). Sarcopenia significantly impacted body composition, reducing muscle mass and body water and increasing visceral fat (p < 0.001). Logistic regression identified body mass index (BMI)(OR = 0.476, 95%CI: 0.352-0.642), skeletal muscle (OR = 0.274, 95%CI: 0.183-0.409), being female (OR = 0.001, 95%CI: 0.000-0.007) and handgrip strength (OR = 0.911, 95%CI: 0.842-0.986) as protective factors against sarcopenia, while higher waist circumference (OR = 1.186, 95%CI: 1.057-1.331) was significant risk factors.

Conclusions: Key strategies to manage sarcopenia in elderly T2DM patients include maintaining an optimal BMI, strengthening grip, regular body composition assessments, and controlling waist circumference. These measures improve muscle strength, reduce risks from visceral fat, and enhance patient outcomes and quality of life.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评价中国某医院老年2型糖尿病患者肌肉减少症的患病率及危险因素
目的:本研究旨在评估中国住院老年2型糖尿病(T2DM)患者肌肉减少症的患病率及相关危险因素,为更有效的管理和预防策略提供信息。方法:我们对中国成都某医院263例老年T2DM患者进行了横断面分析。骨骼肌减少症是根据亚洲骨骼肌减少症工作组(AWGS)的2019年标准诊断的。采用多因素logistic回归分析探讨这些患者肌肉减少症的决定因素。结果:研究显示,老年住院T2DM患者中肌肉减少症患病率为42.2%,其中男性为49.44%,女性为38.51%。肌少症患者年龄较大(72.21±6.841岁vs 68.55±5.585岁),与非肌少症患者相比,短体能性能电池评分(SPPB)、握力和阑尾骨骼肌质量指数(ASMI)较低(p)。结论:老年T2DM患者肌少症治疗的关键策略包括维持最佳BMI、加强握力、定期身体成分评估和控制腰围。这些措施可以增强肌肉力量,降低内脏脂肪的风险,并提高患者的预后和生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Diabetes and Metabolic Disorders
Journal of Diabetes and Metabolic Disorders Medicine-Internal Medicine
CiteScore
4.80
自引率
3.60%
发文量
210
期刊介绍: Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.
期刊最新文献
Association between microsatellite polymorphism in the Heme Oxygenase-1 (HMOX1) gene promoter and type 2 diabetes: an updated meta-analysis. Impact of walnut consumption on glycemic control and anthropometric indices: a systematic review and meta-analysis of randomized controlled trials. Evaluation of glycemia risk index and continuous glucose monitoring-derived metrics in type 1 diabetes: a real-world observational study. Low glucose challenge test result as a potential risk factor for delays in early child development: the Japan environment and children's study. Dietary intake of total, animal, and vegetable protein and cardiometabolic risk factors in patients with type 2 diabetes: using iso-energetic substitution models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1